British Journal of Pharmacology

Papers
(The H4-Index of British Journal of Pharmacology is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Issue Information437
Issue Information345
328
Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer239
Issue Information206
184
Correction to “Melatonin epigenetic potential on testicular functions and fertility profile in varicocele rat model is mediated by silent information regulator 1”181
Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice173
Opportunities of patient‐derived organoids in drug development153
151
Pharmacokinetics and cardioprotective efficacy of intravenous miR‐125b* microRNA mimic in a mouse model of acute myocardial infarction131
GPR84 in physiology—Many functions in many tissues128
Dual action of macrophage miR‐204 confines cyclosporine A‐induced atherosclerosis122
Allosterism in the adenosine A2A and cannabinoid CB2 heteromer118
Scorpion venom heat‐resistant synthesized peptide ameliorates 6‐OHDA‐induced neurotoxicity and neuroinflammation: likely role of Nav1.6 inhibition in microglia117
Animal models of diabetes‐associated vascular diseases: an update on available models and experimental analysis111
Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice110
Quantitative prediction of P‐glycoprotein‐mediated drug–drug interactions and intestinal absorption using humanized mice102
A new class of 5‐HT2A/5‐HT2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins98
Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice96
Deferiprone attenuates neuropathology and improves outcome following traumatic brain injury85
P2X2 receptor subunit interfaces are missense variant hotspots, where mutations tend to increase apparent ATP affinity77
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline74
Novel therapeutic approaches to target neurodegeneration74
A small molecule CFTR potentiator restores ATP‐dependent channel gating to the cystic fibrosis mutant G551D‐CFTR72
Palbociclib blocks neutrophilic phosphatidylinositol 3‐kinase activity to alleviate psoriasiform dermatitis72
Supersulfide biology and translational medicine for disease control71
The respiratory depressant effects of mitragynine are limited by its conversion to 7‐OH mitragynine70
Mas‐related G protein‐coupled receptors in gastrointestinal dysfunction and inflammatory bowel disease: A review70
Exploring pharmacological inhibition of Gq/11 as an analgesic strategy68
Chemosensory signalling in human sperm is controlled by Ca2+ influx via CatSper and Ca2+ clearance via plasma membrane Ca2+ ATPases67
Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin66
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity62
Graph‐based algorithms to dissect long‐distance water‐mediated H‐bond networks for conformational couplings in GPCRs62
Inhibition of HSP90 S‐nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway61
Structural and molecular determinants of mineralocorticoid receptor signalling57
Gβγ subunit signalling underlies neuropeptide Y‐stimulated vasoconstriction in rat mesenteric and coronary arteries55
Issue Information55
Role of NaV1.7 in action potential conduction along human bronchial vagal afferent C‐fibres55
Issue Information54
Translational PK/PD and model‐informed development of JNJ‐67842125, a Fab reversal agent for JNJ‐64179375, a long‐acting thrombin inhibitor52
Targeting mitochondrial proteases for therapy of acute myeloid leukaemia50
Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis49
Macrocyclic diterpenoids from Stellera chamaejasme roots alleviate imiquimod‐induced psoriasiform inflammation via STAT1/S100A9 signalling pathway48
Development of new Kir2.1 channel openers from propafenone analogues47
tiRNA‐Gly‐GCC‐002 promotes epithelial‐mesenchymal transition and fibrosis in lupus nephritis via FKBP5‐mediated activation of Smad46
0.12205410003662